News in brief: Rua’s German stock shortage; Zelira’s finance deal; cultivator nets $1.4m; Neurotech exec steps down; ‘major milestone’ for Argent; Cann Group pharmacy deal by Steve Jones and Martin Lane April 3, 2025April 3, 2025 Rua Bioscience said it delivered record sales in March despite a supply shortage impacting sales in […]
Financial results: Elixinol Wellness; Rua Bioscience; Wellnex Life by Steve Jones March 3, 2025March 5, 2025
Company news: The Entourage Effect/MedReleaf; Biortica; Medical Kiwi; Cannasouth; Rua Bioscience; Ecofibre by Martin Lane and Steve Jones December 18, 2024April 11, 2025
We’re on a journey, says Rua chair, as capital raise falls short by Steve Jones December 7, 2024April 11, 2025
Company news: Wellnex Life; Rua Bioscience; Althea by Steve Jones and Martin Lane November 6, 2024April 11, 2025
Formal mediation fails to resolve Cann Group and Rua legal dispute but talks continue by Steve Jones October 30, 2024October 30, 2024
News in brief: Drug-driving report; Rua Bioscience; Bod Science by Steve Jones October 24, 2024February 25, 2025
Rua Bioscience under pressure to raise funds but looks to ‘positive future’ by Steve Jones October 10, 2024October 10, 2024
Financial results: Rua Bioscience; Elixinol Wellness; Argent Biopharma; Wellnex Life; InhaleRx; Bioxyne by Martin Lane and Steve Jones September 2, 2024September 3, 2024
